Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.62%
#2 Luxxcoin Luxxcoin +45.27%
#3 ResearchCoin ResearchCoin +22.78%
#4 Reactive Network Reactive Network +20.67%
#5 Orderly Network Orderly Network +16.77%
#6 Layer3 Layer3 +13.71%
#7 Bitgert Bitgert +13.08%
#8 Aria.AI Aria.AI +11.86%
#9 Useless Coin Useless Coin +9.66%
#10 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.53%
Coin of the day
Resolv wstUSR Resolv wstUSR
설정
언어
한국어
통화
USD
테마
CSL Limited CSL Limited

CSL Limited

CSL
주식 순위 #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
주가
$99.32
시가총액
$48.20B
변동 (1일)
0.98%
변동 (1년)
-32.14%
국가
AU
거래 CSL Limited (CSL)

카테고리

Healthcare
CSL Limited (CSL)의 주식 분할 이력
CSL Limited 주식 (심볼: CSL)은 총 1회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Oct 18, 2007에 발생했습니다.
Oct 18, 2007 이전에 매수한 CSL 주식 1주는 현재 3주의 CSL 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
2007-10-18 3:1 x3 x3
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 5 x199
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 0 -
US
UCB SA UCB SA
UCB SA
UCB.BR
 0 -
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL